Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease.
Alzheimers Dement (N Y)
; 7(1): e12158, 2021.
Article
en En
| MEDLINE
| ID: mdl-33778150
Alzheimer's disease; MiniMental State Examination; Pittsburgh compound B positron emission tomography; activities of daily living; amyloid; cytokine; glial fibrillary acidic protein; granulocytemacrophage colony stimulating factor; granulocytemacrophage colonystimulating factor; innate immune system; interleukin6; lymphocyte; monocyte; neuroinflammation; neutrophil; sargramostim; tau; tumor necrosis factoralpha; ubiquitin Cterminal hydrolase L1
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
Idioma:
En
Revista:
Alzheimers Dement (N Y)
Año:
2021
Tipo del documento:
Article